
Sale of Panretin gel tubes approved in the United States due to a drug shortage as a result of a manufacturing issue.

Sale of Panretin gel tubes approved in the United States due to a drug shortage as a result of a manufacturing issue.

Patients may be unaware of certain factors regarding prescription drugs they are taking.

Remaining special in the specialty pharmacy space requires innovation.

BRCA2-inherited prostate cancers are predisposed to turn treatment resistant.

The CDC developed a new technique to measure marijuana’s active compounds in milk.

A personalized vaccine may effectively treat HER2-postive breast cancer.

Capsaicin derived from chili peppers shows promise on cultured triple-negative breast cancer cells.

Top news of the day from across the health care landscape.

Naturally-occurring antibodies that fight HIV open new avenues for research.

Senators Chuck Grassley, Bob Casey, and Sherrod Brown last week re-introduced legislation that urges pharmacists to provide care for elderly patients in communities where being seen by a physician may be difficult.

Treatment for rheumatoid arthritis carries numerous difficulties, from physical challenges to gaining access to new drugs.

Anti-TNFs reduce severity and incidence of myocardial infarction in RA patients.

Top news of the day from across the health care landscape.

Improved treatment options for patients with relapsing-remitting multiple sclerosis and primary progressive multiple sclerosis.

Identified cancer driver may be key to increasing survival in metaplastic breast cancer patients.

New drug process may selectively kill cancer cells quicker than current drugs.

Immune checkpoint blockade and gene therapy more effective together than alone in brain cancer.

Unprotected sexual exposure to HIV does not necessarily lead to infection.

Benefits of ART for maternal health and prevention of perinatal transmission outweigh risks in mothers with HIV.

Top news of the week in oncology and cancer drug development.

New at-risk group for skin cancer identified.

Biological products will be designated with 4-letter suffixes devoid of meaning.

FDA finalizes guidance for nonproprietary naming of biological products.

Americans living in rural areas more likely to die from top 5 causes of death, including cancer.

CBI Channel Trends Trade and Specialty Data conference delves into the core topics in the supply chain for both traditional and specialty products.

Beneficial effects seen in blocking the immune response against HIV.

A $1 million competition announced with a goal of reducing lung cancer deaths by 20%.

Top news of the week on Specialty Pharmacy Times.

Top news of the day form across the health care landscape

NCPA emphasizes that a replacement for the Affordable Care Act must preserve prescription drug coverage to help reduce overall health care costs.